close

Enter

Log in using OpenID

Neurovascular Thrombectomy Devices Market Global Trends, Market Share, Industry Size, Growth, Opportunities, and Market Forecast 2019 to 2029

embed
Global neurovascular thrombectomy devices market value over USD 3 billion by 2029 end and register a CAGR of over 6.6% from 2019 to 2029. Neurovascular thrombectomy devices are mainly employed in the arteries, veins, and capillaries to diffuse blood
Neurovascular Thrombectomy Devices Market Global Trends, Market Share,
Industry Size, Growth, Opportunities, and Market Forecast 2019 to 2029
Global neurovascular thrombectomy devices market value over USD 3 billion by 2029
end and register a CAGR of over 6.6% from 2019 to 2029.
Neurovascular thrombectomy devices are mainly employed in the arteries, veins, and
capillaries to diffuse blood clots while causing minimal damage and blood loss.
Diseases such as acute myocardial infarction, peripheral arterial diseases, deep vein
thrombosis, pulmonary embolism, and neurovascular thrombosis conditions.
The growth of neurovascular thrombectomy devices market is attributed to the rising
instances of chronic diseases due to the increasingly sedentary lifestyle of the public.
The deteriorating health conditions and the further rise in geriatric population
globally also further promote the market and its growth. With the advancements in
technology and medical sciences, efficient and improved healthcare infrastructure is
making the procedures minimally invasive and this is helping the market have a
positive favourable trajectory during the forecast period. The developments in the
industry are, for instance, the U.S. FDA has approved numerous thrombectomy
devices. Penumbra Inc, is a global healthcare company focused on innovative
therapies that address challenging medical conditions, received a clearance from the
U.S. FDA to market to help patients with acute ischemic stroke using its new
aspiration thrombectomy system for the revascularization of large vessel occlusions.
Similarly, Medtronic plc, the world's largest medical device company, got its
neurovascular business unit received clearance and got approved by U.S. FDA for the
Riptide(TM) Aspiration System. Furthermore, CERENOVUS, part of the Johnson &
Johnson Medical Devices Companies, was approved by U.S. FDA for EMBOTRAP II
Revascularization Device, a next-generation stent retriever used post an ischemic
stroke, to treat life-threatening blood clots in the brain.
However, the lack of specifically skilled professionals and complicated mechanisms
and devices restrict the market growth. Furthermore, illnesses such as deep vein
thrombosis and pulmonary embolism sometimes due to very undistinct symptoms go
undiagnosed while leading to prolonged serious health conditions, which can be
assisted and erased by awareness to counter ignorance and regular precise
diagnosis.
Request a Sample Report @ https://www.futurewiseresearch.com/requestsample.aspx?id=262&page=requestsample
Neurovascular Thrombectomy Market: Segmentation
By Product Type
> Stent Retriever
> Aspiration Catheter
The aspiration catheter is a type of manual thrombectomy devices which dominated
the market and are expected to continue doing so during the forecast period. These
devices are efficient in power consumption and cost-effective as well.
By End User
> Hospitals
> Neuro-Catheterization Labs
> Specialized Neurosurgery Centers
The hospital's sector occupies major market share as they provide help on an
immediate basis. The increasing need for miniaturized efficient therapeutic devices
and technological advancements to improve minimally invasive surgical techniques
are also responsible for the growth of this segment.
By Region:
> Europe
> North America
> APAC
> Latin America
> Rest of World
North America is expected to lead the market due to technological improvements
and a vast demand for the devices. On the other hand, the demand is rising in the
Asia Pacific and is expected to rise at the highest CAGR during the forecast period.
Competitive Landscape:
> Tier 1 players- established companies in the market with a major market share
> Tier 2 players
> Emerging players which are growing rapidly
> New Entrants
Significant firms operating in this market are Boston Scientific Corporation,
Medtronic Plc., Teleflex Incorporated, Penumbra Inc., Koninklijke Philips N.V.,
AngioDynamics, Inc., Terumo Corporation, Johnson and Johnson, Stryker
Corporation, and Capture Vascular, Inc.
The growing competition and continuous technological advancements have led to
acquisitions by major players in the U.S. thrombectomy devices market. For instance,
in 2017, Philips, one of the largest electronics companies in the world proceeded and
acquisition of The Spectranetics Corporation, a U.S.-based global leader in vascular
intervention and lead management solutions. Similarly, Penumbra Inc., a global
healthcare company focused on innovative therapies that address challenging
medical conditions, executed the acquisition of a controlling interest in its joint
venture with Sixense Enterprises, a leading developer of immersive computing
solutions for companies across industries, primary healthcare gave rise to MVI Health
Inc, to develop virtual reality technology for healthcare applications.
Purchase a Copy of this Premium Research Report At:
https://www.futurewiseresearch.com/checkout.aspx?ReportId=262&license=single
FutureWise Takeaways
> Growth prospects
> SWOT analysis
> Key trends
> Key data points affecting market growth
Objectives of the Study:
> To provide an exhaustive analysis on the neurovascular thrombectomy market by
product, by end-user and by region
> To cater comprehensive information on factors impacting market growth (drivers,
restraints, opportunities, and industry-specific restraints)
> To evaluate and forecast micro-markets and the overall market
> To predict the market size, in key regions (along with countries)—North America,
Europe, Asia Pacific, Latin America, and the Middle East.
> To record evaluate and competitive landscape mapping- product launches,
technological advancements, mergers and expansions
> Profiling of companies to evaluate their market shares, strategies, financials and
core competencies
Inquire further details about this report at: [email protected]
About FutureWise Research:
We specialise in high-growth niche markets, assuring flexibility, agility and
customised solutions for our clients. Through in-depth market insights and
consultancy, we present our clients with the tools they need to be at the forefront of
their industry – a position secured for far more than the near future.
Contact Us:
Company Name: FutureWise Research
Contact Person: Vinay Thaploo
Email: [email protected]
Phone: +44 141 628 9353 / +1 970 279 4295
City: Leeds
Country: United Kingdom
Website: www.futurewiseresearch.com
Author
Merin John
Merin John263   documents Email
Document
Category
Health and Medicine
Views
3
File Size
17 KB
Tags
healthcare, market, health
1/--pages
Report inappropriate content